Sciclone Pharmaceuticals Profile

Sciclone Pharmaceuticals Patent Grants

Treatment of cancer with immune stimulators

Patent Number 9724395 - August 8, 2017

The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the…

Alpha thymosin peptides as vaccine enhancers

Patent Number 8716012 - May 6, 2014

The present invention provides methods of vaccination as well as pharmaceutical combinations and kits for enhancing vaccine effectiveness,…

Treatment of infections with alpha thymosin peptides

Patent Number 8389680 - March 5, 2013

A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The…

Treatment of infections with alpha thymosin peptides

Patent Number 8207294 - June 26, 2012

A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The…

Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

Patent Number 8193152 - June 5, 2012

An immunomodulatory compound is administered to a patient having, or at risk of a hemorrhagic viral infection.

Sciclone Pharmaceuticals Patent Applications

TREATMENT OF ASPERGILLUS INFECTIONS WITH ALPHA THYMOSIN PEPTIDES

Application Number 20120295840 - November 22, 2012

A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The…

PREVENTION OR DELAY OF ONSET OF ORAL MUCOSITIS

Application Number 20110245316 - October 6, 2011

The present invention provides a method for preventing or delaying the onset of oral mucositis, including the onset of ulcerative or severe…

Treatment or Prevention of Hepatitis C with Immunomodulator Compounds

Application Number 20110200558 - August 18, 2011

A method of treatment for treating or preventing hepatitis C (HepC) in a target subject, including administering to the target subject an…

Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of Mucosa

Application Number 20110117211 - May 19, 2011

An immunomodulatory compound is utilized to treat mucosa disease.

TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH ANTIBODIES AGAINST CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4)

Application Number 20100330093 - December 30, 2010

Melanoma or a metastasis thereof is treated in a human patient in a combination therapy which includes administering a melanoma-treating…

Sciclone Pharmaceuticals Federal Litigation Filings

Salpeter-Levy v. SciClone Pharmaceuticals, Inc. et al

California Northern District Court - August 29, 2017

Sciabacucchi v. SciClone Pharmaceuticals, Inc. et al

California Northern District Court - August 17, 2017

Consoli v. SciClone Pharmaceuticals, Inc. et al

California Northern District Court - August 16, 2017

Daley v. SciClone Pharmaceuticals, Inc. et al

California Northern District Court - August 9, 2017

Karner et al v. SciClone Pharmaceuticals, Inc. et al

California Northern District Court - September 7, 2010

Sciclone Pharmaceuticals Federal District Court Decisions

"In re SciClone Pharmaceuticals Securities Litigation"

California Northern District Court - December 1, 2010

STIPULATION AND ORDER Granting Dismissal without Prejudice Pursuant to FRCP 41(a)(1) re 29 Stipulation. Signed by Judge James Ware on…